Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
R&D Systems™ Recombinant Human ErbB2/Her2 Fc Chimera Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Supplier: R&D Systems™ 1129ER01M
This item is not returnable.
View return policy
Description
The Recombinant Human ErbB2/Her2 Fc Chimera Protein is derived from NS0. The Recombinant Human ErbB2/Her2 Fc Chimera Protein has been validated for the following applications: Bioactivity.Specifications
NP_004439 | |
Bioactivity | |
2064 | |
1mg | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
ERBB2 | |
Unconjugated | |
Reconstitute at 100μg/mL in sterile PBS. |
Bioactivity | |
Lyophilized from a 0.2μm filtered solution in PBS. | |
96.8kDa (monomer) | |
Mouse myeloma cell line,NS0-derived human ErbB2/Her2 protein, (N-terminus) Human Erb B2 (Thr23-Thr652) Accession &Num; NP_004439 IEGRMD Human IgG1 (Pro100-Lys330) 6 His-tag (C-terminus) | |
<0.10EU per 1μg of the protein by the LAL method. | |
Recombinant Protein | |
Human | |
>90%, by SDS-PAGE with silver staining |
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?
Provide Content Correction